Join our email list for e-newsletter, upcoming events & information
Home
About
Learn
Advocate
Connect
Resources
More
Alpha PRRT with Pb212 (all NET)
Alpha PRRT with Ac225 (GEPNETs only)
Lu177 DOTATATE + M3814 (Peposertib) (GEPNETs)
Lu177 DOTATATE + Olaparib (GEPNETs)
Lu177 DOTATATE + Triapine (GEPNETs)
Lu177 DOTATATE + Cabozantanib (all NET)
COMPOSE (GEP NETS)
NETTER-P: Lutathera in Adolescent Patients
NET RETREAT of Lu177 Retreatment vs Everolimus in Midgut NET
CABINET: Cabozantinib in Advanced pNET and Carcinoid Tumors
CDK4/6 Abemaciclib
Paltusotine in Carcinoid Syndrome
SORRENTO: Subcutaneous Octreotide for GEPNETs
Surviving Long Peptide Vaccine (SurVaxM) in Metastatic NETs